📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers. (2011)

First Author: Waterhouse BR

Attributed to: Optical Proteomic Technology for In-Situ Analysis of Protein Interaction Networks funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.313

PubMed Identifier: 21908901

Publication URI: http://europepmc.org/abstract/MED/21908901

Type: Journal Article/Review

Volume: 2

Parent Publication: Oncotarget

Issue: 9

ISSN: 1949-2553